NRXP has entered a transformative partnership with Alvogen Pharmaceuticals for the development and marketing of NRX-101.

The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It is also involved in developing Lumateperone, which is in Phase 3 clinical trial for the treatment ...

People with bipolar disorder face stigma and treatment challenges. Despite these barriers, it's possible to live a full and ...

New research suggests that mood swings in bipolar disorder are regulated by two clocks: the body’s 24-hour circadian rhythm ...

A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between ...

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Harael (Harahel) is the angel of Capricorns, born between 11th and 15th January. 😇 As the Guardian Angel of intellectual ...

Bipolar disorder is a complex psychiatric condition that involves mood episodes (mania or depression) that affect mental state, quality of life and the ability to function 1. The heritability of ...

Jan. 27, 2025 — A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between mania and depression, according to new research.

A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural ...